BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yen Y, Schafer CT, Gustavsson M, Eberle SA, Dominik PK, Deneka D, Zhang P, Schall TJ, Kossiakoff AA, Tesmer JJG, Handel TM. Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias. Sci Adv 2022;8:eabn8063. [DOI: 10.1126/sciadv.abn8063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Raynaud P, Gauthier C, Jugnarain V, Jean-alphonse F, Reiter E, Bruneau G, Crépieux P. Intracellular VHHs to monitor and modulate GPCR signaling. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1048601] [Reference Citation Analysis]
2 Torphy RJ, Yee EJ, Schulick RD, Zhu Y. Atypical chemokine receptors: emerging therapeutic targets in cancer. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.09.009] [Reference Citation Analysis]
3 Sarma P, Shukla AK. Resonating with the signaling bias of CXCR7. Mol Cell 2022;82:3318-20. [PMID: 36113411 DOI: 10.1016/j.molcel.2022.08.020] [Reference Citation Analysis]
4 Sarma P, Banerjee R, Shukla AK. Structural snapshot of a β-arrestin-biased receptor. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.08.005] [Reference Citation Analysis]
5 Chen Q, Tesmer JJG. G protein-coupled receptor interactions with arrestins and GPCR kinases: the unresolved issue of signal bias. J Biol Chem 2022;:102279. [PMID: 35863432 DOI: 10.1016/j.jbc.2022.102279] [Cited by in F6Publishing: 2] [Reference Citation Analysis]